5 May – Webinar in connection with year-end report
Alligator hosted a webinar and conference call for investors, analysts, and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the interim report. The presentation was followed by a Q&A session.
The call will be held in English and a recording can be requested via ir@alligatorbioscience.com.
LATEST NEWS
Alligator Bioscience comments on Henlius update on global phase 3 trial with HLX22
Lund, Sweden – 8 June 2026 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today comments on a recent update regarding patient …
Alligator Bioscience comments on Henlius update on long-term follow-up data for HLX22
Lund, Sweden – 22 May 2026 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today comments on a recent update shared by Shanghai …
Bulletin from the annual general meeting in Alligator Bioscience AB on 6 May 2026
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …